Issue 44, 2020

Tyrosine bioconjugation – an emergent alternative

Abstract

Protein bioconjugation is an increasingly important field of research, with wide-ranging applications in areas such as therapeutics and biomaterials. Traditional cysteine and lysine bioconjugation strategies are widely used and have been extensively researched, but in some cases they are not appropriate and alternatives are needed or they are not compatible with one another to enable the formation of dually (and distinctly) modified dual-conjugates (an increasingly desired class of bioconjugates). Here we review the heretofore less explored approach of tyrosine bioconjugation, which is rapidly becoming a constructive alternative/complement to the more well-established strategies. Herein we present an overview of the field, and then focus on promising recent methods that can achieve high conversion and chemoselectivity. This suggests that not only can tyrosine bioconjugation be used in conjunction with cysteine and lysine modification to obtain proteins with multiple different modifications, it is also becoming a stand-alone alternative to these more traditional methods.

Graphical abstract: Tyrosine bioconjugation – an emergent alternative

Article information

Article type
Review Article
Submitted
16 Sep 2020
Accepted
23 Oct 2020
First published
28 Oct 2020
This article is Open Access
Creative Commons BY license

Org. Biomol. Chem., 2020,18, 9018-9028

Tyrosine bioconjugation – an emergent alternative

P. A. Szijj, K. A. Kostadinova, R. J. Spears and V. Chudasama, Org. Biomol. Chem., 2020, 18, 9018 DOI: 10.1039/D0OB01912G

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements